The Robert Wood Johnson University Hospital is an American 965-bed hospital with campuses in New Brunswick, and Somerville, New Jersey, and serves as a flagship hospital of RWJBarnabas Health.

There are 965 beds in Robert Wood Johnson University Hospital.

During the past decade, Robert Wood Johnson University Hospital conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 49 clinical trials were completed, i.e. on average, 98% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 16 clinical trials were completed. i.e. 55.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Robert Wood Johnson University Hospital" #1 sponsor was "Rutgers, The State University of New Jersey" with 27 trials, followed by "Children's Oncology Group" with 15 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 9 trials sponsored, "National Cancer Institute (NCI)" with 6 trials sponsored and "Abbott Medical Devices" with 6 trials sponsored. Other sponsors include 68 different institutions and companies that sponsored additional 65 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Robert Wood Johnson University Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 22 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 4 trials as a collaborator and "University of Pittsburgh" with 4 trials as a collaborator. Other collaborators include 74 different institutions and companies that were collaborators in the rest 71 trials.

According to Clinical.Site data, the most researched conditions in "Robert Wood Johnson University Hospital" are "HIV Infections" (9 trials), "Adult Rhabdomyosarcoma" (3 trials), "COVID-19" (3 trials), "Heart Failure" (3 trials) and "Parkinson Disease" (3 trials). Many other conditions were trialed in "Robert Wood Johnson University Hospital" in a lesser frequency.

Most popular intervention types in "Robert Wood Johnson University Hospital" are "Drug" (86 trials), "Other" (33 trials), "Biological" (26 trials), "Device" (22 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "laboratory biomarker analysis" (8 trials), "cyclophosphamide" (7 trials), "etoposide" (7 trials) and "doxorubicin hydrochloride" (6 trials). Other intervention names were less common.

The vast majority of trials in "Robert Wood Johnson University Hospital" are 115 trials for "All" genders, 17 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 36 active trials in "Robert Wood Johnson University Hospital". 1 are not yet recruiting, 21 are recruiting, 13 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 79 completed trials in Robert Wood Johnson University Hospital, 2 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Robert Wood Johnson University Hospital, 9 "Phase 1" clinical trials were conducted, 41 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 20 trials that are defined as “Not Applicable".

Robert Wood Johnson University Hospital has several departments that took part in Clinical trials: "Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital" - 132 trials